Back
Full-text
Journal article

SARS-CoV-2, COVID-19, skin and immunology - What do we know so far?

  • Novak N Department of Dermatology and Allergy, University Hospital of Bonn, Bonn, Germany.
  • Peng W Department of Dermatology and Allergy, University Hospital of Bonn, Bonn, Germany.
  • Naegeli MC Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Galvan C Department of Dermatology and Venereology, Móstoles Hospital, Madrid, Spain.
  • Kolm-Djamei I Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Brüggen C Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Cabanillas B Department of Dermatology and Allergy, University Hospital of Bonn, Bonn, Germany.
  • Schmid-Grendelmeier P Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Catala A Department of Dermatology and Venereology, Plató Hospital, Barcelona, Spain.
Show more…
  • 2020-07-14
Published in:
  • Allergy. - 2020
allergy
drug hypersensitivity
skin
virus
English The pandemic condition coronavirus disease (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can take asymptomatic, mild, moderate, and severe courses. COVID-19 affects primarily the respiratory airways leading to dry cough, fever, myalgia, headache, fatigue, and diarrhea and can end up in interstitial pneumonia and severe respiratory failure. Reports about the manifestation of various skin lesions and lesions of the vascular system in some subgroups of SARS-CoV-2-positive patients as such features outside the respiratory sphere, are rapidly emerging. Vesicular, urticarial, and maculopapular eruptions and livedo, necrosis, and other vasculitis forms have been reported most frequently in association with SARS-CoV-2 infection. In order to update information gained, we provide a systematic overview of the skin lesions described in COVID-19 patients, discuss potential causative factors, and describe differential diagnostic evaluations. Moreover, we summarize current knowledge about immunologic, clinical, and histologic features of virus- and drug-induced lesions of the skin and changes to the vascular system in order to transfer this knowledge to potential mechanisms induced by SARS-CoV-2.
Language
  • English
Open access status
hybrid
Identifiers
Persistent URL
https://folia.unifr.ch/global/documents/191519
Statistics
Document views: 7 File downloads:
  • fulltext.pdf: 0